Everstar Asset Management LLC Sells 15,106 Shares of The Clorox Company $CLX

Everstar Asset Management LLC cut its stake in shares of The Clorox Company (NYSE:CLX) by 62.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 9,077 shares of the company’s stock after selling 15,106 shares during the quarter. Everstar Asset Management LLC’s holdings in Clorox were worth $941,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of CLX. Vermillion & White Wealth Management Group LLC purchased a new stake in Clorox in the third quarter worth about $25,000. Caitlin John LLC lifted its position in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after buying an additional 253 shares in the last quarter. Darwin Wealth Management LLC bought a new position in shares of Clorox during the 2nd quarter valued at approximately $29,000. Vision Financial Markets LLC grew its stake in shares of Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares during the period. Finally, SHP Wealth Management purchased a new stake in Clorox in the 4th quarter worth approximately $35,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.1%

NYSE CLX opened at $95.90 on Monday. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a market cap of $11.60 billion, a PE ratio of 15.57, a P/E/G ratio of 0.50 and a beta of 0.56. The stock’s 50 day moving average is $95.71 and its 200 day moving average is $104.81.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter last year, the business posted $1.45 earnings per share. The company’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Royal Bank Of Canada decreased their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. The Goldman Sachs Group restated a “sell” rating and set a $83.00 price objective on shares of Clorox in a research report on Friday, May 1st. Wells Fargo & Company lowered their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Finally, Citigroup dropped their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and an average target price of $103.40.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.